Prognostic significance of magnetic resonance imaging (MRI) of bone marrow in previously untreated patients with multiple myeloma.

被引：0
|
作者：
Dimopoulos, MA
Moulopoulos, LA
Delasalle, K
Weber, D
Gika, D
Alexanian, R
机构：
[1] Univ Athens, Sch Med, GR-11527 Athens, Greece
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2398
引用
收藏
页码：536A / 536A
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes
    Takagi, S
    Tanaka, O
    Origasa, H
    Miura, Y
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 277 - 283
  • [32] Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
    Hillengass, Jens
    Fechtner, Kerstin
    Weber, Marc-Andre
    Baeuerle, Tobias
    Ayyaz, Sofia
    Heiss, Christiane
    Hielscher, Thomas
    Moehler, Thomas M.
    Egerer, Gerlinde
    Neben, Kai
    Ho, Anthony D.
    Kauczor, Hans-Ulrich
    Delorme, Stefan
    Goldschmidt, Hartmut
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1606 - 1610
  • [33] Repeatability and reproducibility of apparent diffusion coefficient measurements of bone marrow in magnetic resonance imaging of multiple myeloma patients
    Wennmann, Markus
    Thierjung, Heidi
    Bauer, Fabian
    Groezinger, Martin
    Hielscher, Thomas
    Weru, Vivienn
    Gnirs, Regula
    Sauer, Sandra
    Goldschmidt, Hartmut
    Weinhold, Niels
    Bonekamp, David
    Schlemmer, Heinz-Peter
    Weber, Tim
    Delorme, Stefan
    Rotkopf, Lukas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S48 - S49
  • [34] Neovascularization of bone marrow in patients with diffuse multiple myeloma - A correlative study of magnetic resonance imaging and histopathologic findings
    Baur, A
    Bartl, R
    Pellengahr, C
    Baltin, V
    Reiser, M
    CANCER, 2004, 101 (11) : 2599 - 2604
  • [35] Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients
    Gadó, K
    Nagy, G
    Hasitz, A
    Tóth, BE
    Rimanóczi, E
    Domján, G
    NEUROIMMUNOMODULATION, 2001, 9 (02) : 95 - 102
  • [36] A morphometric study of bone marrow angiogenesis in multiple myeloma.
    Kavantzas, N
    Korkolopoulou, P
    Anargyrou, K
    Kirtsonis, MC
    Thymara, I
    Terpos, E
    Dimopoulou, M
    Boutsis, D
    Viniou, N
    Plata, E
    Patsouris, E
    Davaris, P
    Pangalis, G
    Yataganas, X
    BLOOD, 2002, 100 (11) : 372B - 372B
  • [37] Allogeneic bone marrow transplantation for advanced multiple myeloma.
    Stoetzer, OJ
    Ledderose, G
    Muth, A
    Ott, B
    Salat, C
    Schmid, C
    Hollburg, W
    Schlemmer, M
    Schmidhuber, S
    Pfannes, W
    Ostermann, H
    Schleuning, M
    Kolb, HJ
    BLOOD, 1999, 94 (10) : 389B - 389B
  • [38] The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Actively Relapsing Multiple Myeloma
    Ghosh, Toshi
    Gonsalves, Wilson I.
    Jevremovic, Dragan
    Rajkumar, S. Vincent
    Timm, Michael M.
    Morice, William
    Dispenzieri, Angela
    Dingli, David
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Russell, Stephen J.
    Lust, John A.
    Zeldenrust, Steven R.
    Warsame, Rahma
    Hwa, Yi L.
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    BLOOD, 2016, 128 (22)
  • [39] Prognostic significance of oligoclonal bands and excess bone marrow B lymphocytes in patients with multiple myeloma
    Byrne, E. A. L.
    Rahemtulla, A.
    Naresh, K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 53 - 53
  • [40] Prognostic significance of detectable rearrangements of T cell receptors γ in patients with multiple myeloma.
    Garicochea, B
    Borioli, RA
    Bendit, I
    Martinez, GA
    BLOOD, 2002, 100 (11) : 374B - 374B
12345